Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection
Hyun Phil Shin
Korean J Intern Med. 2023;38(4):454-455. Published online 2023 Jun 30 DOI: https://doi.org/10.3904/kjim.2023.248
Citations to this article as recorded by 
Direct-acting antivirals and beyond: emerging approaches to targeting viral RNA and ribonucleoprotein complexes
Xiaoyan Zuo, Xia Xiao, Xiaojing Dong, Jianwei Wang, Xiaobo Lei
Antiviral Research.2026; 249: 106383. CrossRef